Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT01457612 Completed - Insulin Resistance Clinical Trials

Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)

Start date: October 1, 2011
Phase: N/A
Study type: Interventional

The primary study objective is to investigate the potential chronic beneficial effect of polyphenolics derived from strawberry on impaired insulin signaling in insulin resistant individuals through their ability to modulate oxidative- and inflammatory-markers that lead to devastating disease, including, but not limited to, diabetes and cardiovascular disease.

NCT ID: NCT01457209 Completed - Insulin Resistance Clinical Trials

Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome

PCOS-AcupIR
Start date: October 2011
Phase: Phase 1
Study type: Interventional

The central hypothesis is that acupuncture break the vicious circle of androgen excess and reverse insulin resistance and improve health related quality of life and affective symptoms in overweight and obese women with and without Polycystic Ovary Syndrome.

NCT ID: NCT01456221 Completed - Obesity Clinical Trials

Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents

O3WLIRADOL
Start date: July 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if a supplement containing omega-3 long chain polyunsaturated fatty acids for three months reduce obesity and insulin resistance to obese adolescents if administered together with a hypocaloric diet.

NCT ID: NCT01452048 Completed - Obesity Clinical Trials

Relationship Between Systemic Fatty Acid Availability and Insulin Sensitivity

Start date: September 2011
Phase:
Study type: Observational

The investigators specific aim is to compare the relationship between systemic fatty acid availability and insulin sensitivity in a relatively homogenous population of obese adults. The investigators anticipate 1) greater systemic fatty acid availability will be associated with lower insulin sensitivity and 2) greater systemic fatty acid availability will be associated with greater accumulation of fatty acid intermediates and pro-inflammatory markers.

NCT ID: NCT01452035 Completed - Obesity Clinical Trials

Exercise Dose Response for Improving Insulin Sensitivity

Start date: January 2009
Phase: N/A
Study type: Interventional

Many of the beneficial metabolic effects of endurance exercise training are not due to adaptations to weeks, months, or even years of training, but rather much is due to the response to the most recent exercise session(s). Therefore, the investigators contend that lifestyle interventions for obese individuals should be tailored to optimize the metabolic effects of the most recent exercise session(s). But the "dose" of exercise necessary to evoke these beneficial responses is not known, and the mechanisms responsible for these improvements are poorly understood. The findings from these studies will: 1) establish the minimum "dose" of a single exercise session necessary to improve insulin sensitivity the next day in obese adults, 2) characterize the underlying metabolic factors responsible for the improvement in insulin sensitivity, and 3) assess the cumulative metabolic adaptations that occur over days, weeks, and months of a low-intensity/low-volume lifestyle exercise program. Findings from these studies will provide valuable information for the development of lifestyle programs aimed at maximizing the key metabolic health benefits of each exercise session in obese patients.

NCT ID: NCT01451957 Completed - Obesity Clinical Trials

Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity

Start date: August 2003
Phase: N/A
Study type: Interventional

Alterations in fatty acid mobilization and oxidation may be primary adaptations responsible for the improvements in metabolic health after a single session of endurance exercise. The investigators will determine the effect of a single session of endurance exercise on whole-body fatty acid mobilization and oxidation, IMTG concentration and the expression of factors that regulate these processes in skeletal muscle of 11 women with abdominal obesity (age: 18-45y). In addition, the investigators will evaluate how these factors, and exercise, effect insulin signalling and insulin sensitivity. Every effort will be made to recruit subjects from ethnic and minority groups. Before participating in the study, subjects will be informed of all the procedures and potential risks, and they will sign an informed consent form approved by The University of Michigan Institutional Review Board. Eligible volunteers will participate in three separate trials, in a randomized order. In two trials subjects will eat exactly the same amount of calories, except in one trial they will exercise (eucaloric + exercise) and in the other trial they will remain sedentary (hypercaloric). In a third trial subjects will again remain sedentary but instead they will ingest appropriate calories to maintain caloric balance (eucaloric + sedentary). By doing this the investigators are also able to investigate the effect of acute caloric perturbations on insulin sensitivity, because it is possible that the enhanced insulin sensitivity evident after exercise, as compared to the sedentary state, is due to caloric deficit and not the exercise bout, per se.

NCT ID: NCT01451918 Completed - Insulin Resistance Clinical Trials

Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol

Start date: October 2011
Phase: Phase 2
Study type: Interventional

Resveratrol, an ingredient of red wine and available in Canada in highly purified form as an over-the-counter health supplement, has been shown to have a number of health benefits. Data from in vitro and animal studies suggest that it has beneficial effects on insulin sensitivity and lipid lowering. The investigators are not aware, however, of any mechanistic studies that have examined the effect of highly purified resveratrol in vivo on lipoprotein metabolism in humans. Given the potential therapeutic benefit of resveratrol in correcting the metabolic abnormalities of insulin resistant individuals the investigators plan to examine the effects of resveratrol on intestinal and hepatic lipoprotein production in humans.

NCT ID: NCT01444651 Completed - Obesity Clinical Trials

A Trial of Tadalafil and Glycemic Traits

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to find out if tadalafil can help overweight and obese people metabolize blood sugar more efficiently. The investigators also want to find out if 20 mg/day of tadalafil for 3 months is safe to take without causing too many side effects. The investigators are plan to enroll 100 subjects at Massachusetts General Hospital (MGH).

NCT ID: NCT01441921 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus

EPIRDEM
Start date: September 2011
Phase: N/A
Study type: Interventional

Hypothesis: Chronic intake of pistachios improves glucose metabolism and insulin resistance status thus contributing to decrease the risk of type 2 diabetes mellitus and its associated abnormalities.

NCT ID: NCT01439854 Completed - Insulin Sensitivity Clinical Trials

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

DAPA MITO
Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of the chronic treatment of type 2 diabetes (T2DM) with dapagliflozin on: (1) mitochondrial gene function/expression and insulin signaling/action and (2) oral glucose tolerance and beta cell function. Dapagliflozin is a potent, highly specific inhibitor of renal glucose transport [SGLT2].